Intrathoracic Pressure Regulation (IPR) therapy enhances negative pressure in the chest through the use of Impedance Threshold Devices (ITDs) to improve circulation. Studies have shown that IPR therapy increases blood return to the heart, cardiac output, blood pressure, and decreases intracranial pressure through application of negative intrathoracic pressure. IPR therapy helps the body compensate for low blood pressure and shock through natural physiological mechanisms and has been shown to improve outcomes in animal models of cardiac arrest and bleeding.